Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (12.471)

1

Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults : A phase 3, randomized, active-controlled, multicenter trial

enthalten in: Vaccine | 2024

von Nurdin, A. | Movieta Nency, Y. | Maddeppungeng, M. | +24

2

Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants ≥ 2 and < 43 months of Age : A phase III, multicenter, active controlled, assessor-blinded, randomized, parallel-group study

enthalten in: Vaccine | 2024

von Nakano, T. | Hasegawa, M. | Endo, M. | +2

3

A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Moreau, M. | Alouani, E. | Flecchia, C. | +24

4

Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma : An Exploratory Analysis of AGO-OVAR11/ICON-7

enthalten in: Laboratory investigation; a journal of technical methods and pathology | 2024

von Heublein, S. | Pfisterer, J. | du Bois, A. | +18

5

Efficacy and safety of ivermectin in patients with mild COVID-19 in Japan and Thailand

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Mikamo, H. | Takahashi, S. | Yamagishi, Y. | +17

6

Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS) : a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Neurology | 2024

von Mercuri, E. | Vilchez, J. | Boespflug-Tanguy, O. | +25

ErratumIn: Lancet Neurol. 2024 Apr 18;:. - PMID 38643778

7

Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless) : a phase 3, randomised, double-blind, double-dummy, multicentre trial

enthalten in: The Lancet. Neurology | 2024

von Espay, A. | Stocchi, F. | Pahwa, R. | +87

8

Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia : analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial

enthalten in: The Lancet. Oncology | 2024

von Kater, A. | Arslan, �. | Demirkan, F. | +24

9

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2024

von Wu, Y. | Dziadziuszko, R. | Ahn, J. | +120

10

Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia : a randomized phase 3 trial with 5-year outcomes

enthalten in: Journal of cancer research and clinical oncology | 2024

von Tian, J. | Song, Y. | Zhang, G. | +24

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1248]